Back to Journals » ClinicoEconomics and Outcomes Research » Volume 2 » default
![](https://www.dovepress.com/cr_data/cache/journal_image/29/cope/thumb_100_1000_100.jpg)
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
- View all (882)
- Volume 16, 2024 (35)
- Volume 15, 2023 (67)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Archive: Volume 2, 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Inpatient charges and mental illness: Findings from the Nationwide Inpatient Sample 1999–2007
Jim E Banta, Ivorie Belk, Kedon Newton, et al
ClinicoEconomics and Outcomes Research 2010, 2:149-158
Published Date: 11 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells
Thomas Bart
ClinicoEconomics and Outcomes Research 2010, 2:141-147
Published Date: 5 October 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Testing the generalizability of national reimbursement rates with respect to local setting: the costs of abdominal aortic aneurysm surgery in Denmark
Søren Løvstad Christensen, Mette Kjoelby, Lars Ehlers
ClinicoEconomics and Outcomes Research 2010, 2:135-139
Published Date: 14 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pharmacotherapy in the management of early Parkinson’s disease: cost-effectiveness and patient acceptability
Esther Cubo
ClinicoEconomics and Outcomes Research 2010, 2:127-134
Published Date: 6 September 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
On the decision rules of cost-effective treatment for patients with diabetic foot syndrome
John E Goulionis, Athanassios Vozikis, VK Benos, et al
ClinicoEconomics and Outcomes Research 2010, 2:121-126
Published Date: 17 August 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years
Luca Degli Esposti, Stefania Saragoni, Paolo Batacchi, et al
ClinicoEconomics and Outcomes Research 2010, 2:113-120
Published Date: 28 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis
Rikke Søgaard, Jan Sørensen, Louise Linde, et al
ClinicoEconomics and Outcomes Research 2010, 2:105-112
Published Date: 16 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Impact of disability on different domains of health-related quality of life in the noninstitutionalized general population
Javier Mar, Isabel Larrañaga, Arantzazu Arrospide, et al
ClinicoEconomics and Outcomes Research 2010, 2:97-103
Published Date: 14 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost effectiveness and quality of life considerations in the treatment of hepatitis C infection
H Jafferbhoy, W Gashau, JF Dillon
ClinicoEconomics and Outcomes Research 2010, 2:87-96
Published Date: 14 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-effectiveness analysis of corticosteroid inhaler devices in primary care asthma management: A real world observational study
Linda Kemp, John Haughney, Neil Barnes, et al
ClinicoEconomics and Outcomes Research 2010, 2:75-85
Published Date: 1 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Clinical and economic considerations of antiobesity treatment: a review of orlistat
Armineh Zohrabian
ClinicoEconomics and Outcomes Research 2010, 2:63-74
Published Date: 5 July 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pharmacoeconomic considerations in the treatment of breast cancer
Athanasios Pallis, Vasiliki Tsiantou, Efi Simou, et al
ClinicoEconomics and Outcomes Research 2010, 2:47-61
Published Date: 15 June 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness
Firas Badin, John Hayslip
ClinicoEconomics and Outcomes Research 2010, 2:37-45
Published Date: 7 April 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
Shalini Naik, Khalid M Kamal, Patricia A Keys, et al
ClinicoEconomics and Outcomes Research 2010, 2:25-36
Published Date: 9 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury
Rashid Kazerooni, Mark Bounthavong
ClinicoEconomics and Outcomes Research 2010, 2:15-23
Published Date: 5 March 2010
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Use of electronic medical records in oncology outcomes research
Gena Kanas, Libby Morimoto, Fionna Mowat, et al
ClinicoEconomics and Outcomes Research 2010, 2:1-14
Published Date: 24 February 2010